Tag: AstraZeneca
Sun Pharma & AstraZeneca enter into license agreement for novel oncology...
As per the terms of the agreement, Sun Pharma will be responsible for development, regulatory filings and manufacturing the products covered in the agreement while AstraZeneca will exclusively promote and distribute these products in China...................
AstraZeneca set to expand its clinical research footprint in India
The establishment of a new Development Operations Centre by AstraZeneca at Bengaluru supports the development of innovative medicines and hosts clinical trial experts focused on core therapeutic areas................
AstraZeneca announces finalists of the Unnati Healthcare Innovation Challenge, joins hands...
AstraZeneca strengthens innovation partnerships with NASSCOM – CoE IoT and Unnati to address Non-Communicable Diseases (NCDs) in India. Leif Johansson, Non-Executive Chairman of the Board, AstraZeneca PLC visits India...…………...
AstraZeneca well placed to use Medtech to expand in Chinese healthcare...
The Chinese Internet giants will develop smart health services, AI-assisted screening and diagnosis tools for the British pharma giant...……….
AstraZeneca receives marketing permission for Durvalumab (ImfinziTM) in India
Durvalumab is the only immunotherapy approved for patients with unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) and was granted US FDA ‘breakthrough therapy’ designation on July 31, 2017.....................
AstraZeneca expands its Global Medicines Development Centre in India
GMD India will support AstraZeneca’s global established medicines portfolio; build capabilities in regulatory science, and clinical and patient safety................
World Asthma Day: AstraZeneca equips Bengaluru city traffic police to fight...
The company distributed close to 500 anti-pollution masks to traffic policemen besides conducting asthma education and awareness sessions for the department personnel................
PM Modi’s Sweden Visit: AstraZeneca to invest $90 million in India...
Following the signature of the bilateral innovation partnership for a sustainable future between Sweden and India, AstraZeneca announces an investment of USD 90 million in India over the next 5 years to develop local skills, build scientific innovation........
Healthcare firms finding obesity market a challenge to penetrate, says GlobalData
The latest failure of three anti-obesity drugs to provide the anticipated results could lead to the companies taking a cautious approach while investing to develop further drugs in the area.............
AstraZeneca set to expand its Global Medicines Development group in Bengaluru
In order to support its expansion plans, the AstraZeneca is working with experienced recruitment partners to support the search for individuals with the right competence by end 2018...........